Intera Oncology Recalls Intera 3000 Hepatic Artery Infusion Pump for Faster Than Expected Flow Rates

Serious injuries or death may result from the use of these devices. This is a Class I recall, the most serious type of recall.

If your email program has trouble displaying this email, view as a webpage. Intera Oncology Recalls Intera 3000 Hepatic Artery Infusion Pump Due to Faster Than Expected Flow Rates That May Impact Infusion Delivery Intera Oncology is recalling the Intera 3000 Hepatic Artery Infusion Pump after receiving reports from clinicians that the pumps were delivering medications (flow rate) faster than expected. Medication delivery at a faster than expected rate may cause serious injury or death. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death. Read More Questions? Customers with questions or concerns about this recall should contact Intera Oncology at (800) 660-2660 or support@interaoncology.com.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA